A Rheumatoid Arthritis (RA) Study Treating Signs and Symptoms of RA in People With RA & Receiving Methotrexate
Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
This clinical study is investigating AMG 719, an investigational drug, for the treatment of
patients who have Rheumatoid Arthritis and who are taking Methotrexate. AMG 719 is a drug
which is self-injected beneath the skin (similarly to the way insulin is self-injected by
diabetics). Patients on this study are on study for 28-weeks. They visit the study facility
at least 11 times while participating in the study.